arginine has been researched along with aphidicolin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 8 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Adachi, S; Anai, H; Hanada, K; Ishizaki, T; Kawano, M; Matsuoka, S; Nishida, M; Nishida, Y; Okuma, T; Tanaka, K; Terabayashi, T; Tomo, T; Tsumura, H | 1 |
Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K | 1 |
Andreassen, PR; Margolis, RL | 1 |
Bradbury, EM; Hamaguchi, J; Roberge, M; Th'ng, J | 1 |
Charron, M; Hancock, R | 1 |
Dainiak, N; Hanspal, M; Kreczko, S; Strauss, PR | 1 |
Richter, A; Strausfeld, U | 1 |
Lönn, S; Lönn, U | 1 |
Bertrand, R; Jenkins, J; Pommier, Y; Solary, E | 1 |
Farinelli, SE; Greene, LA | 1 |
Durka, S; Hueber, A; Weller, M | 1 |
12 other study(ies) available for arginine and aphidicolin
Article | Year |
---|---|
Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition.
Topics: Aphidicolin; Arginine; Asparagine; Camptothecin; DNA; DNA Topoisomerases, Type I; Naphthyridines; Tyrosine | 2022 |
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells.
Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells.
Topics: 2-Aminopurine; Animals; Aphidicolin; Cell Cycle; Cell Line; Cricetinae; DNA; Flow Cytometry; G1 Phase; G2 Phase; Hydroxyurea; Kidney; Kinetics; Microtubules; Mimosine; Mitotic Index; Protein Kinase Inhibitors; Teniposide; Time Factors | 1992 |
[Isolation of drug-resistant mutant cells].
Topics: Alkylating Agents; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aphidicolin; Camptothecin; Cell Separation; Drug Resistance; Etoposide; Humans; Hydroxamic Acids; Lovastatin; Monensin; Nucleic Acids; Teniposide; Toxins, Biological; Tunicamycin | 1991 |
The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.
Topics: Animals; Aphidicolin; Cell Cycle; Cells, Cultured; Chromosomes; Demecolcine; Diterpenes; DNA Damage; DNA Topoisomerases, Type II; G1 Phase; G2 Phase; Histones; Metaphase; Mitosis; Nuclear Envelope; Phosphorylation; Protamine Kinase; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1990 |
DNA topoisomerase II is required for formation of mitotic chromosomes in Chinese hamster ovary cells: studies using the inhibitor 4'-demethylepipodophyllotoxin 9-(4,6-O-thenylidene-beta-D-glucopyranoside).
Topics: Animals; Aphidicolin; Cell Line; Chromatin; Chromosomes; Cricetinae; Cricetulus; Diterpenes; DNA Replication; DNA Topoisomerases, Type II; Female; Flow Cytometry; Kinetics; Mitosis; Ovary; Teniposide; Thymidine; Topoisomerase II Inhibitors; Tritium | 1990 |
DNA topoisomerase inhibitors block erythropoiesis and delay hemoglobinization in vitro.
Topics: Aphidicolin; Camptothecin; Cell Differentiation; Cell Division; Diterpenes; Erythrocytes; Erythropoiesis; Hemoglobins; Humans; In Vitro Techniques; Teniposide; Topoisomerase I Inhibitors | 1989 |
Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
Topics: Animals; Aphidicolin; Cell Line; Chromatin; Diterpenes; DNA Replication; DNA Topoisomerases, Type I; Kinetics; Podophyllotoxin; Simian virus 40; Teniposide; Topoisomerase II Inhibitors; Virus Replication | 1988 |
5,6-Dichloro-1-beta-O-ribofuranosylbenzimidazole induces DNA damage by interfering with DNA topoisomerase II.
Topics: Aphidicolin; Cells, Cultured; Chemical Precipitation; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA; Electrophoresis, Agar Gel; Etoposide; Humans; Novobiocin; Proteins; Ribonucleosides; Teniposide; Topoisomerase II Inhibitors | 1987 |
Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Aminoquinolines; Aphidicolin; Apoptosis; Benzamides; Calcium; Calmodulin; Camptothecin; Cell Cycle; Chromatin; Cyclosporine; DNA; Egtazic Acid; Ethers, Cyclic; Humans; Isoquinolines; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Microscopy, Electron; Naphthalenes; Okadaic Acid; Phosphoprotein Phosphatases; Piperazines; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Polycyclic Compounds; Protein Kinase C; Spermine; Staurosporine; Teniposide; Tetradecanoylphorbol Acetate; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Zinc | 1993 |
Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support.
Topics: Animals; Aphidicolin; Apoptosis; Cell Cycle; Cell Division; Ciclopirox; Cyclic AMP; Deferoxamine; G1 Phase; Mimosine; Mitosis; Nerve Growth Factors; Neurons; Nocodazole; PC12 Cells; Pyridones; Rats; Superior Cervical Ganglion; Teniposide; Thionucleotides | 1996 |
CD95-mediated apoptosis: no variation in cellular sensitivity during cell cycle progression.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Aphidicolin; Apoptosis; Camptothecin; Cell Cycle; Cell Death; Cisplatin; Culture Media, Serum-Free; Doxorubicin; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Gene Expression; HeLa Cells; Humans; Hydroxyurea; Jurkat Cells; Membrane Glycoproteins; Nimustine; Nocodazole; Paclitaxel; Sensitivity and Specificity; Teniposide; Tumor Cells, Cultured; Vincristine | 1998 |